New York (PRWEB) March 17, 2014
CinG-X™ announces the launch of their patent protected supplement combining the beneficial and synergistic effects of panax ginseng and cinnamon bark extracts. This combination helps optimize and maintain healthy blood glucose levels and promote overall health and wellness.
The CinG-X™ proprietary formulation contains highly processed forms of cinnamon and panax ginseng. Cinnamon and panax ginseng help enhance the body’s ability to process sugar but also limit the detrimental effects of high blood glucose on the brain—research supports that supplementing with CinG-X™ can help balance glucose levels in the blood while supporting cognitive function. Additionally, supplementing a diet with CinG-X™ may help individuals have lessened feelings of fatigue, and help support cognitive function, including memory.
“The formulation of CinG-X™ utilizes cinnamon and panax ginseng to support healthy blood glucose levels, a major factor in cardiovascular and neurological functions,” said Michael Arnkvarn, CEO of The CinG-X Corporation. “After extensive research on the active ingredients and the supplement’s efficacy as a whole, we are excited to launch CinG-X™ and introduce a new natural solution to help maintain blood glucose levels.”
A study most recently performed by the U.S. Agricultural Research Service found that cinnamon reduces blood sugar levels in persons with type II diabetes. A total of 60 people with type II diabetes, 30 men and 30 women were divided randomly into six groups—some given cinnamon daily, while others received placebo capsules. The cinnamon was consumed for 40 days followed by a 20-day washout period. The results of this study demonstrate that daily intake of cinnamon reduces serum glucose, triglyceride, LDL cholesterol, and total cholesterol in people with type II diabetes and suggest that the inclusion of cinnamon in the diet of people with type II diabetes will reduce risk factors associated with diabetes and cardiovascular disease.
“There are 125 million people who are insulin resistant, where glucose builds up in the blood instead of being absorbed into the bloodstream. These high blood sugar levels can affect both the mind and the body,” explained Dr. Marc Cantillon, the Chief Medical Advisor for CinG-X™. “CinG-X™ represents a significant drug-free advance that offers long-term hope for these people to live a happier and healthier life.”
CinG-X™ is a patent protected supplement, which is comprised of proprietary extracts of cinnamon bark and panax ginseng. This unique process is done in such a way that it is 50 times more concentrated than cinnamon in its natural form. In addition, its panax ginseng is 50 times more potent than vitamin C as an antioxidant. The extraction process eliminates all of the toxins, which are naturally present in cinnamon, allowing one to consume this unique and powerful product safely, with no side effects.
CinG-X™ is now available for purchase in the United States and Canada, and can be ordered on the company’s website at http://www.cingx.com or by calling customer service at 877-366-5469 from anywhere in the USA or 844-222-1636 from anywhere in Canada.
For more information about CinG-X™ please visit http://www.cingx.com.
About CGX Life Science, Inc.
The CinG-X Corporation of America is a wholly-owned subsidiary of CGX Life Sciences Inc. CGX is a Nevada corporation dedicated to the manufacture and distribution of high quality nutraceuticals to the North American marketplace. Its products, targeted to provide safe, alternative treatments or to assist in the prevention of specific medical conditions, contain active ingredients formulated from natural herbal and botanical components. Each of CGX’s nutraceuticals will be marketed only after extensive research has been completed on its active ingredients and after the efficacy of its products has been supported by independent analysis. CGX’s singular commitment is to provide its customers with safe, effective and natural products designed to assist in the prevention of chronic conditions, which have limited or poor therapeutic alternatives.